Bruker (BRKRP) Capital Expenditures (2010 - 2026)

Bruker (BRKRP) has 17 years of Capital Expenditures data on file, last reported at $24.2 million in Q1 2026.

• For the quarter ending Q1 2026, Capital Expenditures fell 6.92% year-over-year to $24.2 million; the trailing twelve-month figure through Mar 2026 stood at $89.0 million (down 25.77% YoY), and the FY2025 full-year result was $90.8 million, down 21.25% from the prior year.
• Capital Expenditures for Q1 2026 stood at $24.2 million, up from $22.6 million in the prior quarter.
• Across five years, Capital Expenditures topped out at $57.7 million in Q3 2022 and bottomed at $17.9 million in Q2 2022.
• The 5-year median for Capital Expenditures is $24.6 million (2024), against an average of $27.4 million.
• The widest annual swing landed in 2022, when Capital Expenditures surged 253.99%; it then plunged 53.38% in 2023.
• A 5-year view of Capital Expenditures shows it stood at $34.6 million in 2022, then declined by 8.96% to $31.5 million in 2023, then rose by 16.51% to $36.7 million in 2024, then slumped by 38.42% to $22.6 million in 2025, then gained by 7.08% to $24.2 million in 2026.
• The last three Capital Expenditures figures came in at $24.2 million (Q1 2026), $22.6 million (Q4 2025), and $20.9 million (Q3 2025), per Business Quant data.

Peer Comparison